Martin is a results-oriented executive with over 20 years of experience in the clinical research industry. He has a proven track record of leading project delivery, building strategic client relationships, and team building. He holds a PhD in Molecular Pharmacology and has progressed through leadership roles at PRA Health Sciences and ICON.
Colleagues describe him as an open, honest, and hardworking leader who sets high standards of integrity for himself and his team. He is adept at building strong internal and external relationships to drive growth and client satisfaction. He appears to be a supportive mentor, celebrating the achievements of his team members.
He uniquely combines a PhD in Molecular Pharmacology with marketing qualifications, blending deep scientific expertise with commercial and client management skills.
Read the full overview →While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They prefer to do thorough analysis of any situation. They are more likely than others to negotiate on pricing and terms.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.